Introduction
Allergic contact dermatitis (ACD) has an approximate prevalence of 20 % [1] . We do not know the exact prevalence of systemic contact dermatitis (SCD), but it is thought to be much less common. While most sensitized patients improve with cutaneous allergen avoidance, others require avoidance of systemic sources, such as a specialized diet to also limit oral exposure to allergens. Low-allergen diets have been developed for specific common allergens, and these diets are recommended in practice when necessary. Early reports of somewhat successful hypo-sensitization are being revisited, with the potential for future therapy.
Epidemiology
The incidence and prevalence of ACD in the general population has been difficult to study. A thoughtful review by Thyssen et al., in 2007 estimated the median prevalence of contact allergy in the general population as 21.2 %, with a weighted average prevalence of 19.5 %. The most common allergens noted were nickel, thimerosal, and fragrance mix. The median nickel allergy prevalence was noted to be 8.6 % [1] .
Unfortunately, no epidemiological data exist for SCD in the general population. Challenges in the collection of this information include the large number of allergens that can cause SCD, the clinical basis for the diagnosis of SCD, and the diversity of clinical presentations of SCD. However, a meta-analysis of 17 studies of oral nickel exposure estimated that 1 % of nickelsensitive patients may react systemically to everyday nickel exposure (0.22-0.35 mg nickel), and 10 % may react to a diet composed of foods rich in nickel (0.55-1.33 mcg nickel) [2] . Furthermore, European literature has noted the emergence of a "systemic nickel allergy syndrome" or SNAS, defined as nickel-induced SCD with extracutaneous symptoms. Of 1,696 patients referred to allergy units in Italy, 98 (5.78 %) were diagnosed with SNAS [3] .
Pathogenesis
SCD is defined as non-cutaneous exposure to an allergen causing dermatitis in a person who is already cutaneously sensitized [4] . The pathogenesis of ACD has been well-described, and involves an immune-mediated sensitization and elicitation phase. After sensitization, exposure to the allergen administered through a route other than skin contact is thought to elicit an immune response that produces cutaneous manifestations. Common routes of exposure include oral, intra-articular, intramuscular, intravenous, inhalation, and subcutaneous, among others [5] . While ACD has been described as a type IV delayed-type hypersensitivity, SCD may also involve a type III immune response, as antigen-antibody complexes have been found in the skin [6] , and in the blood [7] , in such reactions.
Presentation
The clinical presentation of SCD can vary widely. While SCD may be clinically indistinguishable from ACD, unique presentations are also recognized. Baboon syndrome has been used to describe a SCD manifesting as erythema of the buttocks and flexural skin [8] . If this presentation is drug-related, it has been denoted symmetric drug-related intertriginous and flexural exanthema (SDRIFE) [9] . Vesicular hand (and possibly foot) dermatitis has also been described and is most commonly associated with metals, specifically oral administration of nickel, cobalt and chromium [10] [11] [12] [13] [14] [15] , as can the ingestion of spices [16] . Similarly, perianal dermatitis [17, 18] and "recall" dermatitis, reactivation of a patch test site [19, 20] or of prior dermatitis [21, 22] , have been ascribed to SCD.
Diagnosis
The epicutaneous patch test remains the gold standard for diagnosing ACD. When patients do not clinically improve with prescribed topical avoidance of relevant allergens, SCD should be added to the differential diagnosis. Certain allergens are more likely than others to cause SCD, and consideration of the potential relevance of non-cutaneous sources of exposure should be undertaken. The diagnosis of SCD is supported when a patient improves after avoidance of exposure by oral or another route to the proven allergen. Typically, rechallenge of a patient with this allergen via the non-cutaneous route helps confirm the diagnosis.
Prognosis
With regard to oral exposure, ability to adhere to a diet may impact the prognosis of a patient with SCD. Some diets are more difficult to follow than others, and individual patient preference for foods may also affect success or failure with prescribed low-allergen diets.
Additionally, individuals may have different thresholds of response, and some more sensitive patients may have to adhere more stringently than others to control symptoms.
Treatment
& SCD with oral allergen exposure is managed with dietary avoidance (Table 1) . Poor compliance or inability to maintain restriction in the setting of persistent symptoms may merit consideration of phototherapy or immunosuppressant therapy. Oral hypo-sensitization has been reported as a possible future treatment for the systemic nickel allergy syndrome (SNAS) subgroup of patients. & An algorithmic approach to management of dermatitis in a patient with clinically relevant positive epicutaneous patch test can be found in Fig. 1 . can leach into foods. Acidic foods such as citrus, tomato-based meals, and vinegar may also contribute to this phenomenon [26] . Similarly, stainless steel utensils should not be used while cooking acidic foods [27] . & Both processed foods and canned foods may have higher than expected nickel content due to packaging and processing equipment [28] . & The soil in which a food is grown may affect the food's nickel content [29] . & Absorption of nickel may vary depending on patient health and overall diet. Vitamin C [30] and iron [31] decrease the dietary absorption of nickel [28] . Taking a chewable 500 mg or 1000 mg vitamin C tablet with food at every meal may decrease absorption of nickel [24••] .
Diet and lifestyle
Patients with iron-deficiency anemia may absorb more nickel from the diet than expected [27, 32] . Avoidance of any nickel-containing multivitamin is recommended [24••] . & If constipation occurs following a low-nickel diet, taking a stool softener such as docusate sodium may be helpful [24••] .
Cobalt
& Cobalt is a constituent of vitamin B12. Naturally occurring B12, comprised of adenosylcobalamin and methylcobalamin, does not cause hypersensitivity reactions [13] . However, there are reports of reactions to synthetically derived B12, both cyanocobalamin and hydroxycobalamin [33, 34] . & It is thought that it is the cobalt itself, rather than the vitamin B12 in foods, that contributes to SCD [13] . & A low-cobalt points-driven diet has been developed to facilitate dietary cobalt restriction. Patients are limited to 12 points daily, and portioned foods are assigned a point value of 1-7 depending on cobalt content [13] . & Brazil nuts, cow liver and herbal/homeopathic remedies are not permitted on this diet due to elevated cobalt levels [13] . & Contributions to the overall cobalt exposure burden include smoking and industrial sources [35] .
Chromate & Avoiding foods high in chromate may be necessary in chromiumsensitive patients [36] . These foods include red wine [37] , whole grains and bran, potatoes, meats, fruits such as apples and bananas, orange and grape juice, beans and nuts, vegetables such as broccoli and green beans, brewer's yeast, black pepper, coffee and tea [38] [39] [40] . & Canned food, hard water, and chromium-containing drinks and supplements should be avoided [36] . & Cooking in aluminum cookware decreases the chromium content of food while using stainless steel cookware increases the chromium content [36] . & Foods containing simple sugars, such as fructose and sucrose, may help eliminate chromium [36] .
Balsam of Peru (BOP)
& BOP (Myroxylon pereirae) is a commonly used fragrant sap-derived substance from a tree in Central America. It consists of a conglomerate of numerous potential allergens, including vanillin, cinnamates, benzoates, ferulic acid, coniferin, and eugenol subgroups [41••] . & Numerous foods may contain spices and flavorings problematic for individuals sensitized to BOP or any of its many components. On a low-BOP diet, it is important to avoid citrus (including essence, oil, and peel); sweet baked goods; spices such as cinnamon, cloves, vanilla, curry, allspice, anise, and ginger; pickled foods; tomato-based sauces; spicy condiments; select alcohols such as certain wines, gin and vermouth; chocolate; ice cream; and flavored soft drinks, including colas. Any spiced tobacco or medicinal product should also be avoided [42] . & It is likely that not all patients with BOP-related systemic contact dermatitis need to avoid all subgroups, and Scheman et al. [41••] recommend further classification and testing for the subgroups eugenol, vanillin, cinnamates, benzoates, ferulic acid, and coniferin. Knowing the specific BOP allergen subgroup(s) can help identify more specific foods to avoid, rather than eliminating the broad list above [41••] .
Propylene glycol
& Propylene glycol is a humectant found in some prepared food products.
& It is listed on the ingredient label, and may be found in numerous products [ 
Compositae (Asteraceae)
& Avoidance of consumable members of the Compositae family may be necessary, including chamomile tea, lettuce, echineacea, chicory, and endive [45] .
Formaldehyde
& Formic acid is a metabolite of aspartame, and aspartame may need to be avoided in formaldehyde-sensitive patients [46] . Some foods that contain aspartame include chewable vitamins, weight-loss drinks, protein powders and bars, diet drinks including sodas, and low-calorie or sugar-free foods [43••] .
Parabens
& Parabens are used as preservatives, and are not highly allergenic [47] . Foods with higher content of parabens include pickles, prepared baked goods, syrup, and jelly/jam/marmalade [48] . 
Sorbic acid

Interventional procedures
& The use of ultraviolet light treatment in hand eczema can be effective [52] . It is also used for localized and diffuse dermatitis. Narrow-band ultraviolet B (NBUVB) light, ultraviolet A (UVA) light, and topical or systemic psoralen with ultraviolet A (PUVA) light are potential options for phototherapy. Contraindications to phototherapy include exogenous or endogenous sun-sensitivity and a personal history of melanoma, while history of nonmelanoma skin cancer is a relative contraindication.
Emerging therapies
Hypo-sensitization & Hypo-sensitization is an emerging treatment in the field of systemic allergic contact dermatitis. Oral hypo-sensitization has been reported to have had some success in the treatment of cobalt-sensitive [53] , and nickel-sensitive patients [54•, 55] . & A recently published randomized, double-blind, placebocontrolled trial addressed patients with a diagnosis of SNAS. These patients had not only skin symptoms, but also extracutaneous complaints, commonly gastrointestinal, which were associated with nickel consumption. The group treated with the highest dose of nickel weekly was able to tolerate reintroduction of nickel-rich foods better than the placebo group, and required less use of rescue medications. Higher nickel doses after treatment were required to elicit a symptomatic flare as compared to pre-treatment. Gastrointestinal symptoms were statistically significantly improved in this same group as compared to placebo; skin symptoms were improved, though not statistically significantly [54•] . & The mechanism of hypo-sensitization is still being investigated.
Following nickel oral hypo-sensitization therapy, there are cytokine changes from a primarily Th2 profile to an increase in IL-10 [56] , which is a regulatory cytokine [57] . Cavani et al. [58] postulate that the proliferation and differentiation of T regulatory cells may lead to increased tolerance of nickel after hyposensitization therapy.
